scholarly journals Heparin-bonded ePTFE Graft (Propaten) Versus Standard PTFE Graft for Arteriovenous Fistula in Hybrid Recanalization of Post-thrombotic Venous Obstruction.

2019 ◽  
Vol 58 (6) ◽  
pp. e476-e477
Author(s):  
Mert Dumantepe ◽  
Murat Okten ◽  
Hasan Karabulut
2018 ◽  
Vol 19 (4) ◽  
pp. 366-369 ◽  
Author(s):  
Afsha Aurshina ◽  
Anil Hingorani ◽  
Ahmad Alsheekh ◽  
Pavel Kibrik ◽  
Natalie Marks ◽  
...  

Objective: It has been a widely accepted practice that a previous placed pacemaker, automatic implantable cardioverter defibrillators, or central line can be a contraindication to placing a hemodialysis catheter in the ipsilateral jugular vein. Fear of dislodging pacing wires, tunneling close to the battery site or causing venous obstruction has been a concern for surgeons and interventionalists alike. We suggest that this phobia may be unfounded. Methods: A retrospective review was conducted of patients in whom hemodialysis catheters were placed over a period of 10 years. For each hemodialysis catheter that was placed, perioperative chest X-ray performed was used to evaluate for pre-existing pacemakers and central lines. The position and laterality of placement of the hemodialysis catheter along with presence of arteriovenous fistula with functional capacity for access were noted. Results: A total of 600 hemodialysis catheters were placed in patients over the period of 10 years. The mean age of the patients was 73.6 ± 12 years with a median age of 76 years. We found 20 pacemakers or automatic implantable cardioverter defibrillators and 19 central lines on the same side of the neck as the hemodialysis catheter that was placed in the ipsilateral jugular vein. No patient exhibited malfunction or dislodgment of the central line, the pacemaker, or automatic implantable cardioverter defibrillator or evidence of upper extremity venous obstruction based upon signs symptoms or duplex exams. Conclusion: Based on our experience, we suggest that placement of hemodialysis catheter in the internal jugular vein ipsilateral to the pre-existing catheter/leads is safe and spares the contralateral limb for arteriovenous fistula creation.


Author(s):  
Omar Yacob ◽  
Vijaywant Brar ◽  
Arooje Towheed ◽  
Cyrus Hadadi ◽  
Susan O'Donoghue ◽  
...  

Subclavian venous obstruction is a common complication after cardiac device placement. Patients typically remain asymptomatic but at times may present with acute symptoms due to thrombus formation immediately after device placement or years later, due to chronic obstruction, with pain and swelling. Various techniques have been attempted to resolve symptoms in patients with chronic lead-related subclavian obstruction but are associated with a high recurrence of restenosis. Drug coated balloons (DCB) have been used subsequently after pre-dilation with high-pressure balloons, of the stenosed region, in patients with arteriovenous fistula obstruction, and have shown promising results. We discuss the utilization of DCB in our patient with chronic subclavian obstruction due to a permanent pacemaker lead.


2015 ◽  
Vol 30 (1_suppl) ◽  
pp. 42-49 ◽  
Author(s):  
RLM Kurstjens ◽  
R de Graaf ◽  
ME Barbati ◽  
MAF de Wolf ◽  
JHH van Laanen ◽  
...  

Introduction Post-thrombotic obstruction can be adequately treated by percutaneous transluminal angioplasty and stenting. When post-thrombotic trabeculations extend below the femoral confluence, proper inflow can be facilitated by endophlebectomy and creation of an arteriovenous fistula. The aim of this study was to investigate whether it is more favourable to place the arteriovenous fistula at the cranial or caudal end of the endophlebectomy to prevent stenosis or occlusion. Methodology We retrospectively analysed the clinical data of all patients who underwent a hybrid procedure in our two centres. Demographics, interventional details and post-operative imaging were collected. Results Data on 42 limbs with cranially and 23 limbs with caudally placed arteriovenous fistulas were collected. Post-thrombotic disease of the profunda femoral vein alone or in combination with the femoral vein was observed more often in the cranial group. The caudal group more often received a smaller sized and straight polytetrafluoroethylene fistula, while the cranial group comprised a significantly higher amount of stented segments. Logistic regression showed that only reduced femoral inflow (hazard ratio 2.934 (95%CI, 1.148–7.494)) was a significant predictor of stent stenosis and/or occlusion. Logistic regression for risk of occlusion showed a significant influence of stent-related complications (hazard ratio 4.691 (95%CI, 1.205–18.260)) and a tendency towards influence of arteriovenous fistula geometry in favour of the cranially placed fistula. Conclusion Placement of the arteriovenous fistula in the cranial part of the endophlebectomy during hybrid recanalisation may result in a more favourable outcome, yet this tendency was not statistically significant. Moreover, femoral inflow is pivotal in maintaining patency and should thus be adequately assessed pre-operatively.


Sign in / Sign up

Export Citation Format

Share Document